Lupin Receives USFDA Nod for Seizure Treatment Drug
Mumbai based pharmaceutical major Lupin Ltd on Wednesday announced that it has received approval from the U.S. Food and Drug Administration to market a generic medication used in the treatment of seizures in the United States.The approval...
anda
brivaracetam
briviact
bse
drug approval
genericmedication
india
lupin
oral solution
pharmaceutical industry
pharmaceutical sales
seizures
us market
usfda
New Delhi, February 24: Alembic Pharmaceuticals on Tuesday announced that it has received final approval from the US Food and Drug Administration to market its generic version of Efinaconazole Topical Solution 10 percent in the United States.The approval marks a significant regulatory...